Immuneering Presents Data At 2026 AACR Conference On Pancreatic Cancer Supporting Atebimetinib's Mechanisms Designed To Extend Survival In Pancreatic Cancer

(MENAFN - GlobeNewsWire - Nasdaq) - Stable or increased weight was twice as common among pancreatic cancer patients in the atebimetinib + mGnP study, compared to those in a benchmark study - - ...